Forschung & Innovation
Publikationen
Endothelin-1 genetic polymorphism (SNP rs5370-TT) fails to predict resistance to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
PMU Autor*innen
Simon Peter Gampenrieder, Markus Steiner, Clemens Hufnagl, Gabriel Rinnerthaler, Florian Huemer, Patrick Morre, Cornelia Hauser-Kronberger, Richard Greil
Alle Autor*innen
Simon Peter Gampenrieder, Markus Steiner, Clemens Hufnagl, H. Hackl, Gabriel Rinnerthaler, T. Westphal, Florian Huemer, C. Monzo-Fuentes, Patrick Morre, Cornelia Hauser-Kronberger, Richard Greil
Fachzeitschrift
ANNALS OF ONCOLOGY